US Broker Ratings

Sanofi (SNY) Stock Analysis: Exploring a 19.97% Upside Potential in the Healthcare Sector

Sanofi (SNY), a prominent player in the global healthcare sector, stands out for its diverse portfolio that spans immunology, oncology, and a range of vaccines. With..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 45.4% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) is a pivotal player in the U.S. healthcare landscape, operating an extensive network of healthcare facilities. With a market capitalization of..

CVS Health Corporation (CVS): Investor Outlook Reveals 23.91% Potential Upside with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a leader in the healthcare sector, specifically within the healthcare plans industry, presents a compelling investment opportunity with a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating the 3.43% Upside Potential

For investors seeking opportunities in the healthcare sector, Dr. Reddy’s Laboratories Ltd (NYSE: RDY) presents a compelling case. As a key player in the specialty and..

Veeva Systems Inc. (VEEV) Stock Analysis: A 64% Potential Upside Amid Strong Buy Ratings

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences sector, is attracting significant attention with a substantial 64.13% potential upside..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth with a 23.1% Revenue Surge and a Forward P/E of 55.22

Exact Sciences Corporation (EXAS), a prominent player in the healthcare sector, is making waves with its specialized focus on diagnostic and research innovations. Headquartered in Madison,..

HCA Healthcare, Inc. (HCA) Stock Analysis: Unveiling a 23.71% Potential Upside

For investors eyeing the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) presents an intriguing opportunity. As a heavyweight in the medical care facilities industry, HCA boasts..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 6.37% Dividend Yield Amidst a Challenging Market

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, is drawing investor attention with its robust dividend yield of 6.37%, a standout figure amidst current..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 14.10% Potential Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, is presenting itself as an intriguing option for investors eyeing the healthcare..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant Offers 30% Upside Potential

Investors interested in the healthcare sector should closely examine Cencora, Inc. (NYSE: COR), a formidable player in the medical distribution industry. With a market capitalization of..

GSK plc (GSK) Stock Analysis: Evaluating a 5.90% Potential Upside Amid Healthcare Innovations

GSK plc (NYSE: GSK), a leading player in the healthcare sector, offers a compelling investment opportunity for those interested in the drug manufacturing industry. With a..

Novo Nordisk A/S (NVO) Stock Analysis: A Potential 13.39% Upside in Healthcare’s Heavyweight

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture investor attention with its promising potential upside of 13.39%, as highlighted by..

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 17.54% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector, specifically in diagnostics and research, boasts a market capitalization of $21.74 billion. The company is..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unpacking the 46.95% Potential Upside for Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a pioneering force in the biotechnology sector, specializing in the innovative field of ribonucleic acid interference (RNAi) therapeutics. With..

IDEXX Laboratories (IDXX) Stock Analysis: A 29.6% Upside in the Booming Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable force in the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Unveiling a 16.82% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a pioneering force in the biotechnology sector, is garnering significant attention from investors seeking robust growth and solid financial performance. With..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating Growth Potential and Analyst Consensus

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization..

Baxter International (BAX) Stock Analysis: Exploring a 21.78% Potential Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Baxter International Inc. (NYSE: BAX) presents an intriguing opportunity. Despite recent challenges, this established player in..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 42.72% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, IQVIA Holdings, Inc. (IQV) presents a compelling case. With a market capitalization of $27.24 billion, IQVIA is a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds